| Afatinib plus vinorelbine versus trastuzumab plus vinorelbine in patients with HER2-overexpressing metastatic breast cancer who had progressed on one previous trastuzumab … N Harbeck, CS Huang, S Hurvitz, DC Yeh, Z Shao, SA Im, KH Jung, ... The Lancet Oncology 17 (3), 357-366, 2016 | 145 | 2016 |
| Single‐dose versus multiple instillations of epirubicin as prophylaxis for recurrence after transurethral resection of pTa and pT1 transitional‐cell bladder tumours: a … B Ali‐el‐Dein, A Nabeeh, M El‐Baz, S Shamaa, A Ashamallah British journal of urology 79 (5), 731-735, 1997 | 118 | 1997 |
| Intravesical epirubicin versus doxorubicin for superficial bladder tumors (stages pTa and pT1): a randomized prospective study B Ali-El-Dein, M El-Baz, ANM Aly, S Shamaa, A Ashamallah The Journal of urology 158 (1), 68-74, 1997 | 92 | 1997 |
| Phase II study of viscum fraxini-2 in patients with advanced hepatocellular carcinoma M Mabed, L El-Helw, S Shamaa British journal of cancer 90 (1), 65-69, 2004 | 90 | 2004 |
| Marrow versus peripheral blood for geno-identical allogeneic stem cell transplantation in acute myelocytic leukemia: influence of dose and stem cell source shows better outcome … ALWPAECGBMTE Norbert C. Gorin, Myriam Labopin, Vanderson Rocha, William ... BLOOD 102 (8), 3043-3051, 2003 | 61 | 2003 |
| Doxorubicin-loaded nanoparticles for patients with advanced hepatocellular carcinoma after sorafenib treatment failure (RELIVE): a phase 3 randomised controlled trial P Merle, JF Blanc, JM Phelip, G Pelletier, JP Bronowicki, Y Touchefeu, ... The Lancet Gastroenterology & Hepatology 4 (6), 454-465, 2019 | 47 | 2019 |
| Angiogenesis factor pattern differs in acute lymphoblastic leukemia and chronic lymphocytic leukemia S Aref, O Salama, S Shamaa, M El-Refaie, H Mourkos Hematology 12 (4), 319-324, 2007 | 39 | 2007 |
| Nephropathy in asymptomatic patients with active Schistosoma mansoni infection M Sobh, F Moustafa, A El-Arbagy, M Shebab El-Din, S Shamaa, G Amer International Urology and Nephrology 22 (1), 37-43, 1990 | 39 | 1990 |
| Clinical impact of breast cancer stem cells in metastatic breast cancer patients MA Elbaiomy, T Akl, N Atwan, AA Elsayed, M Elzaafarany, S Shamaa Journal of oncology 2020, 2020 | 29 | 2020 |
| Computed tomography assessment of hepatic metastases of breast cancer with revised response evaluation criteria in solid tumors (RECIST) criteria (Version 1.1): inter-observer … FEI Ghobrial, MS Eldin, AAKA Razek, NI Atwan, SSA Shamaa Polish Journal of Radiology 82, 593, 2017 | 22 | 2017 |
| Prognostic implications of NPM1 mutations and FLT3 internal tandem duplications in Egyptian patients with cytogenetically normal acute myeloid leukemia S Shamaa, N Laimon, DA Aladle, E Azmy, DM Elghannam, DA Salem, ... Hematology 19 (1), 22-30, 2014 | 21 | 2014 |
| Low-dose versus standard-dose gemcitabine infusion and cisplatin for patients with advanced bladder cancer: a randomized phase II trial—an update R Haggag, K Farag, F Abu-Taleb, S Shamaa, AR Zekri, T ELBolkainy, ... Medical Oncology 31, 1-6, 2014 | 19 | 2014 |
| Diagnostic and prognostic utility of t (14; 18) in follicular lymphoma H Deghiedy, M Fouda, D Shahin, S Shamaa, A El-Bedewy, ... Acta Haematologica 118 (4), 231-236, 2007 | 19 | 2007 |
| Inter-observer agreement of whole-body computed tomography in staging and response assessment in lymphoma: the Lugano classification AAKA Razek, S Shamaa, MA Lattif, HH Yousef Polish Journal of Radiology 82, 441, 2017 | 18 | 2017 |
| High-dose chemotherapy plus non-cryopreserved autologous peripheral blood stem cell transplantation rescue for patients with refractory or relapsed Hodgkin disease M Mabed, S Shamaa Biology of Blood and Marrow Transplantation 12 (9), 942-948, 2006 | 16 | 2006 |
| Genetic susceptibility in Hodgkin’s lymphoma M Hafez, H El-Tahan, Z El-Morsi, M El-Ziny, Y Al-Tonbary, S Shamaa, ... Familial cancer, 175-179, 1985 | 16 | 1985 |
| JAK2, CALR, and MPL mutations in Egyptian patients with Classic Philadelphia-negative myeloproliferative neoplasms EA Soliman, S El-Ghlban, S Abd El-Aziz, A Abdelaleem, S Shamaa, ... Clinical Lymphoma Myeloma and Leukemia 20 (10), e645-e651, 2020 | 14 | 2020 |
| Prognostic value of some inflammatory markers in patients with lymphoma N Hamed Anber, AH El-Sebaie, NHE Darwish, SA Mousa, SS Shamaa Bioscience Reports 39 (3), BSR20182174, 2019 | 12 | 2019 |
| Phase II study of low-dose fixed-rate infusion of gemcitabine combined with cisplatin and dexamethasone in resistant non-Hodgkin lymphoma and correlation with Bcl-2 and MDR … S Elsamany, MU Farooq, M Elsirafy, S Shamaa, M Sakr Medical Oncology 31, 1-8, 2014 | 12 | 2014 |
| Evaluation of the diagnostic and prognostic value of syndecan-1 in acute leukemia patients R Alghandour, MA Ebrahim, H Ghazy, S Shamaa, Z Emarah, ... Cureus 12 (9), 2020 | 8 | 2020 |
Mohamed MabedProfessor of HematologyVerified email at mans.edu.eg
